Discontinuation report NAPROXEN SODIUM TABLETS

Last updated on 2019-01-04 History
Report ID 71228
Drug Identification Number 02385007
Brand name NAPROXEN SODIUM TABLETS
Common or Proper name NAPROXEN TAB 220MG
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) NAPROXEN SODIUM
Strength(s) 220MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-09-20
Remaining supply date 2018-09-20
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-01-04 French Compare
v1 2019-01-04 English Compare

Showing 1 to 2 of 2